Antigen-specific immunity following hematopoietic stem cell transplantation

Area of Science:

• Immunology
• Transplantation Medicine
• Oncology

Background:

• Immune reconstitution after hematopoietic stem cell transplantation (HSCT) is typically assessed by T cell numbers and response to mitogens.
• However, effective protection against infections and tumors post-HSCT is linked to antigen-specific immunity, not just T cell presence.

Purpose of the Study:

• To highlight the importance of antigen-specific T lymphocytes in immune reconstitution following HSCT.
• To explore the origins and development of antigen-specific T cells after HSCT, considering T cell-depleted versus non-T cell-depleted protocols.

Main Methods:

• The study reviews existing literature and immunological principles related to T cell development and function post-HSCT.
• It contrasts immune reconstitution pathways based on the presence or absence of T cells in the HSCT inoculum.

Main Results:

• Antigen-specific T lymphocytes post-HSCT can originate from donor inoculum or develop de novo from hematopoietic stem cells.
• T cell-depleted HSCT necessitates thymic processing for generating naive and antigen-specific T cells.
• Defects in thymopoiesis can lead to delayed or absent naive T cells, impairing antigen-specific immunity.

Conclusions:

• Focusing solely on T cell counts or general immune function is insufficient for evaluating HSCT outcomes.
• The development of robust antigen-specific immunity, dependent on thymopoiesis, is critical for protection against pathogens and cancer recurrence post-HSCT.